InvestorsHub Logo

GAB

Followers 23
Posts 2745
Boards Moderated 0
Alias Born 01/02/2003

GAB

Member Level

Re: biotechnician post# 249821

Friday, 05/08/2020 2:04:54 PM

Friday, May 08, 2020 2:04:54 PM

Post# of 458325
Cassava Sciences had a productive quarter with its research programs in Alzheimer’s disease,” said Remi Barbier, President & CEO. “As a result, we anticipate having top-line results for our Phase 2b study of PTI-125, our lead drug candidate for Alzheimer’s, EARLIER than mid-2020.”

From Twitter.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News